US Patent 7592467 Inhibitors of prolyl endopeptidase
Patent 7592467 was granted and assigned to Probiodrug on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+103 characters)
Article
Patent abstract
The present invention relates to novel inhibitors of prolyl endopeptidase of formula (1)
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07592467 Inhibitors of prolyl endopeptidase US Patent 7592467 Inhibitors of prolyl endopeptidase
Infobox
Patent Number
0759246700
Patent Number
759246700
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075924670
Date of Patent
September 22, 2009
0Patent Application Number
114005820
Date Filed
April 7, 2006
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075924670
Date of Patent
September 22, 2009
0Patent Application Number
114005820
Date Filed
April 7, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07592467 Inhibitors of prolyl endopeptidase
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07592467
Date of patent
September 22, 2009
Patent application number
11400582
Date Filed
April 7, 2006
Patent primary examiner
Find more entities like US Patent 7592467 Inhibitors of prolyl endopeptidase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.